中文 | English
Return
Total: 7 , 1/1
Show Home Prev Next End page: GO
MeSH:(Janus Kinase Inhibitors/therapeutic use*)

2.Recent research on tofacitinib in the treatment of pediatric rheumatic diseases.

Shi-Hai ZHOU ; Ya-Qun XIONG ; Ya CHEN

Chinese Journal of Contemporary Pediatrics 2022;24(4):447-453

4.Mechanism of sophocarpine in treating experimental colitis in mice.

Jian-mei ZHANG ; Ya-bi ZHU ; Xing DENG ; Chang-xiong WANG ; Shuang-mei LUAN ; Yue-xiang CHEN

China Journal of Chinese Materia Medica 2015;40(15):3081-3087

5.Guidelines for the management of myeloproliferative neoplasms.

Chul Won CHOI ; Soo Mee BANG ; Seongsoo JANG ; Chul Won JUNG ; Hee Jin KIM ; Ho Young KIM ; Soo Jeong KIM ; Yeo Kyeoung KIM ; Jinny PARK ; Jong Ho WON

The Korean Journal of Internal Medicine 2015;30(6):771-788

6.Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials.

Gwan Gyu SONG ; Sang Cheol BAE ; Young Ho LEE

The Korean Journal of Internal Medicine 2014;29(5):656-663

7.Inhibition of Janus activated kinase-3 protects against myocardial ischemia and reperfusion injury in mice.

Young Bin OH ; Min AHN ; Sang Myeong LEE ; Hyoung Won KOH ; Sun Hwa LEE ; Suhn Hee KIM ; Byung Hyun PARK

Experimental & Molecular Medicine 2013;45(5):e23-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 7 , 1/1 Show Home Prev Next End page: GO